{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T15:53:15Z","timestamp":1692460395581},"reference-count":9,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.eururo.2011.07.034","type":"journal-article","created":{"date-parts":[[2011,7,23]],"date-time":"2011-07-23T18:48:01Z","timestamp":1311446881000},"page":"872-873","source":"Crossref","is-referenced-by-count":5,"title":["Should We Stop Using Botulinum Neurotoxin Type A in Patients With Neurogenic Detrusor Overactivity After Development of Secondary Resistance?"],"prefix":"10.1016","volume":"60","author":[{"given":"Donatella","family":"Pistolesi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianluca","family":"Giannarini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Stampacchia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cesare","family":"Selli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2011.07.034_bib0005","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.eururo.2008.09.009","article-title":"Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: a European consensus report","volume":"55","author":"Apostolidis","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2011.07.034_bib0010","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1212\/WNL.49.1.189","article-title":"Human response to botulinum toxin injection: type B compared with type A","volume":"49","author":"Sloop","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.eururo.2011.07.034_bib0015","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/01.ju.0000108844.10235.f1","article-title":"Botulinum toxin type B for type A resistant bladder spasticity","volume":"171","author":"Pistolesi","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2011.07.034_bib0020","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1097\/01.ju.0000108407.53880.6a","article-title":"Botulinum toxin type B injection for management of type A resistant neurogenic detrusor overactivity","volume":"171","author":"Reitz","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2011.07.034_bib0025","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s11255-005-8681-1","article-title":"Autonomic side effects of botulinum toxin type B intravesical injections: report of 4 cases and review of the literature","volume":"38","author":"Ghei","year":"2006","journal-title":"Int Urol Nephrol"},{"issue":"Suppl 1","key":"10.1016\/j.eururo.2011.07.034_bib0030","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1468-1331.2006.01439.x","article-title":"Immunological aspects of Botox, Dysport and Myobloc\/NeuroBloc","volume":"13","author":"Dressler","year":"2006","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.eururo.2011.07.034_bib0035","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/mds.1238","article-title":"Botulinum toxin antibody type A titres after cessation of botulinum toxin therapy","volume":"17","author":"Dressler","year":"2002","journal-title":"Mov Disord"},{"key":"10.1016\/j.eururo.2011.07.034_bib0040","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.urology.2010.03.023","article-title":"Antibody formation following botulinum toxin type A (Dysport) injection in children with intractable bladder hyper-reflexia","volume":"76","author":"Kajbafzadeh","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2011.07.034_bib0045","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1002\/mds.21051","article-title":"Secondary nonresponsiveness to botulinum toxin A in cervical dystonia: the role of electromyogram-guided injections, botulinum toxin A antibody assay, and the extensor digitorum brevis test","volume":"21","author":"Cordivari","year":"2006","journal-title":"Mov Disord"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030228381100772X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030228381100772X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T05:35:14Z","timestamp":1543642514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030228381100772X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":9,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S030228381100772X"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2011.07.034","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}